|
KMID : 1011920130140020010
|
|
International Journal of Arrhythmia
2013 Volume.14 No. 2 p.10 ~ p.13
|
|
|
Flecainide
|
|
Rhee Kyoung-Suk
|
|
|
Abstract
|
|
|
|
Flecainide is a class IC antiarrhythmic agent that has an important role as part of the rhythm-control strategies in patients with atrial fibrillation (AF). Current guidelines recommend the use of flecainide in carefully selected groups of patients with AF, who do not have structural heart disease. These recommendations include the use of flecainide for the cardioversion of recent-onset AF, pretreatment prior to direct-current cardioversion, out-of-hospital acute oral therapy (the “pill-in-the-pocket” approach), and the ongoing maintenance of sinus rhythm.
|
|
|
KEYWORD
|
|
|
antiarrhythmic agent, flecainide
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|